2016
DOI: 10.1371/journal.pone.0159850
|View full text |Cite
|
Sign up to set email alerts
|

A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis

Abstract: Here we characterize a new animal model that spontaneously develops chronic inflammation and fibrosis in multiple organs, the non-obese diabetic inflammation and fibrosis (N-IF) mouse. In the liver, the N-IF mouse displays inflammation and fibrosis particularly evident around portal tracts and central veins and accompanied with evidence of abnormal intrahepatic bile ducts. The extensive cellular infiltration consists mainly of macrophages, granulocytes, particularly eosinophils, and mast cells. This inflammato… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
24
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 13 publications
(26 citation statements)
references
References 29 publications
2
24
0
Order By: Relevance
“…NIF mice spontaneously developed chronic liver inflammation and fibrosis initiated by a transgenic population of NKT cells while 2,4αβNOD.Rag2 +/− littermate control mice did not 34 . To gain further insight into the mechanisms underlying this process, we followed the kinetics according to the liver phenotype in mice from 3 to 18 weeks of age.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…NIF mice spontaneously developed chronic liver inflammation and fibrosis initiated by a transgenic population of NKT cells while 2,4αβNOD.Rag2 +/− littermate control mice did not 34 . To gain further insight into the mechanisms underlying this process, we followed the kinetics according to the liver phenotype in mice from 3 to 18 weeks of age.…”
Section: Resultsmentioning
confidence: 99%
“…We have previously described a new model for liver fibrosis, the nonobese diabetic inflammation and fibrosis (NIF) mouse 33 , 34 , in which a transgenic NKT cell population induces chronic inflammation and fibrosis. Here, we demonstrate that, in this model, transgenic NKT cells drive a type 1 inflammatory response through the production of pro-inflammatory cytokines involving the activation of the NLRP3 inflammasome and promote the switch to a predominantly anti-inflammatory, reparative/profibrotic response through the production of type 2 cytokines such as IL-13.…”
Section: Introductionmentioning
confidence: 99%
“…ab15160, Abcam) 58 , anti-KRT7 (IHC, 1:4000, rabbit monoclonal, cat. ab181598, Abcam) 59 , anti-LEFTY1 (IHC, 1:1000, D7E3G rabbit polyclonal, cat. 12647, Cell Signalling), anti-OLFM4 (IHC, 1:200, D1E4M rabbit monoclonal, cat.…”
Section: Methodsmentioning
confidence: 99%
“…However, the renal pathology was ameliorated in TLR4-deficient mice, suggesting that CD1d-dependent NKT cells played a protective role in NAFLD-associated renal inflammation and fibrosis via suppressing TLR4-mediated signaling function [ 67 ]. The Rag2 −/− mice overexpressing TCR Vα3.2 and Vβ9 chains showed increased generation of type II NKT cells and spontaneously developed hepatitis and liver fibrosis, in which type II NKT cells produced sufficient Th2 cytokines and contributed to the liver fibrosis [ 68 ].…”
Section: Innate Immune Cells In the Pathogenesis Of Fibrosismentioning
confidence: 99%